Literature DB >> 21173796

Non-canonical NF-κB signaling pathway.

Shao-Cong Sun1.   

Abstract

The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex. This pathway depends on the inducible processing of p100, a molecule functioning as both the precursor of p52 and a RelB-specific inhibitor. A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing. A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization. Tight control of the fate of NIK is important, since deregulated NIK accumulation is associated with lymphoid malignancies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21173796      PMCID: PMC3193406          DOI: 10.1038/cr.2010.177

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  104 in total

1.  In vitro selection of optimal RelB/p52 DNA-binding motifs.

Authors:  Liudmila V Britanova; Vsevolod J Makeev; Dmitry V Kuprash
Journal:  Biochem Biophys Res Commun       Date:  2007-11-09       Impact factor: 3.575

Review 2.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

3.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

Review 4.  Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation.

Authors:  Gioacchino Natoli; Susanna Chiocca
Journal:  Sci Signal       Date:  2008-01-08       Impact factor: 8.192

5.  IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

Authors:  James E Vince; W Wei-Lynn Wong; Nufail Khan; Rebecca Feltham; Diep Chau; Afsar U Ahmed; Christopher A Benetatos; Srinivas K Chunduru; Stephen M Condon; Mark McKinlay; Robert Brink; Martin Leverkus; Vinay Tergaonkar; Pascal Schneider; Bernard A Callus; Frank Koentgen; David L Vaux; John Silke
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

6.  IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

Authors:  Eugene Varfolomeev; John W Blankenship; Sarah M Wayson; Anna V Fedorova; Nobuhiko Kayagaki; Parie Garg; Kerry Zobel; Jasmin N Dynek; Linda O Elliott; Heidi J A Wallweber; John A Flygare; Wayne J Fairbrother; Kurt Deshayes; Vishva M Dixit; Domagoj Vucic
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

7.  Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs.

Authors:  Ping Xie; Laura L Stunz; Karen D Larison; Baoli Yang; Gail A Bishop
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 8.  Multiple roles of TRAF3 signaling in lymphocyte function.

Authors:  Gail A Bishop; Ping Xie
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

Authors:  Jonathan J Keats; Rafael Fonseca; Marta Chesi; Roelandt Schop; Angela Baker; Wee-Joo Chng; Scott Van Wier; Rodger Tiedemann; Chang-Xin Shi; Michael Sebag; Esteban Braggio; Travis Henry; Yuan-Xiao Zhu; Homer Fogle; Tammy Price-Troska; Gregory Ahmann; Catherine Mancini; Leslie A Brents; Shaji Kumar; Philip Greipp; Angela Dispenzieri; Barb Bryant; George Mulligan; Laurakay Bruhn; Michael Barrett; Riccardo Valdez; Jeff Trent; A Keith Stewart; John Carpten; P Leif Bergsagel
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

10.  RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.

Authors:  Sergio Vaira; Trevor Johnson; Angela C Hirbe; Muhammad Alhawagri; Imani Anwisye; Benedicte Sammut; Julie O'Neal; Wei Zou; Katherine N Weilbaecher; Roberta Faccio; Deborah Veis Novack
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

View more
  388 in total

1.  Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype.

Authors:  Hye Sun Kuehn; Julie E Niemela; Karthik Sreedhara; Jennifer L Stoddard; Jennifer Grossman; Christian A Wysocki; M Teresa de la Morena; Mary Garofalo; Jingga Inlora; Michael P Snyder; David B Lewis; Constantine A Stratakis; Thomas A Fleisher; Sergio D Rosenzweig
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

2.  IKKβ-induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vector.

Authors:  Emily L Hopewell; Crystina C Bronk; Michael Massengill; Robert W Engelman; Amer A Beg
Journal:  Eur J Immunol       Date:  2012-01-13       Impact factor: 5.532

Review 3.  C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses.

Authors:  Lara M Kingeter; Xin Lin
Journal:  Cell Mol Immunol       Date:  2012-01-16       Impact factor: 11.530

Review 4.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 5.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

6.  The Role of the Phylogenetically Conserved Cochaperone Protein Droj2/DNAJA3 in NF-κB Signaling.

Authors:  Yoshiki Momiuchi; Kohei Kumada; Takayuki Kuraishi; Takeshi Takagaki; Toshiro Aigaki; Yoshiteru Oshima; Shoichiro Kurata
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

7.  Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes.

Authors:  Xinzhi Li; Yongsen Wu; Yue Song; Na Ding; Min Lu; Linna Jia; Yujun Zhao; Ming Liu; Zheng Chen
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

8.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

Review 9.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

10.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.